CA2140427A1 - A two component fibrin-glue composition for improving in vitro fertilization - Google Patents

A two component fibrin-glue composition for improving in vitro fertilization

Info

Publication number
CA2140427A1
CA2140427A1 CA002140427A CA2140427A CA2140427A1 CA 2140427 A1 CA2140427 A1 CA 2140427A1 CA 002140427 A CA002140427 A CA 002140427A CA 2140427 A CA2140427 A CA 2140427A CA 2140427 A1 CA2140427 A1 CA 2140427A1
Authority
CA
Canada
Prior art keywords
component
composition
fibrin
glue
fibrinogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002140427A
Other languages
English (en)
French (fr)
Inventor
Efrach Barnea
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Opperbas Holding BV
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2140427A1 publication Critical patent/CA2140427A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
    • A61L27/225—Fibrin; Fibrinogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Transplantation (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Dermatology (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA002140427A 1992-07-18 1993-07-09 A two component fibrin-glue composition for improving in vitro fertilization Abandoned CA2140427A1 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP92112295.8 1992-07-18
EP92112295 1992-07-18
EP93105298.9 1993-03-30
EP93105298 1993-03-30

Publications (1)

Publication Number Publication Date
CA2140427A1 true CA2140427A1 (en) 1994-02-03

Family

ID=26131003

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002140427A Abandoned CA2140427A1 (en) 1992-07-18 1993-07-09 A two component fibrin-glue composition for improving in vitro fertilization

Country Status (12)

Country Link
JP (1) JPH08502035A (fi)
KR (1) KR950702434A (fi)
AT (1) ATE151295T1 (fi)
AU (1) AU4566893A (fi)
CA (1) CA2140427A1 (fi)
CZ (1) CZ5495A3 (fi)
DE (1) DE69309685T2 (fi)
FI (1) FI950194A0 (fi)
HU (1) HUT71873A (fi)
IL (1) IL106293A0 (fi)
SK (1) SK5095A3 (fi)
WO (1) WO1994002182A1 (fi)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2159469C (en) * 1993-03-30 2004-06-22 Uri Martinowitz Two component fibrin glue
US5411885A (en) * 1993-12-17 1995-05-02 New York Blood Center, Inc. Methods for tissue embedding and tissue culturing
WO1996003160A1 (en) * 1994-07-26 1996-02-08 Children's Medical Center Corporation Fibrin-cell suspension for construction of new tissue
JPH11502431A (ja) * 1995-01-16 1999-03-02 バクスター インターナショナル インコーポレイテッド 手術後の癒着を防止するための架橋化フィブリンの自己支持シート様材料
ATE439150T1 (de) * 1997-11-17 2009-08-15 Haemacure Corp Ein hyaluronsäurederivat enthaltende fibrinsiegel-oder fibrinklebmasse

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT369990B (de) * 1981-07-28 1983-02-25 Immuno Ag Verfahren zur herstellung eines gewebeklebstoffes
US4904259A (en) * 1988-04-29 1990-02-27 Samuel Itay Compositions and methods for repair of cartilage and bone
CH681693A5 (fi) * 1991-02-28 1993-05-14 Pentapharm Ag
SE9101853D0 (sv) * 1991-06-17 1991-06-17 Jonas Wadstroem Improved tissue ashesive

Also Published As

Publication number Publication date
JPH08502035A (ja) 1996-03-05
DE69309685D1 (de) 1997-05-15
KR950702434A (ko) 1995-07-29
HU9500141D0 (en) 1995-03-28
IL106293A0 (en) 1993-11-15
WO1994002182A1 (en) 1994-02-03
ATE151295T1 (de) 1997-04-15
FI950194A (fi) 1995-01-17
SK5095A3 (en) 1995-07-11
CZ5495A3 (en) 1995-06-14
AU4566893A (en) 1994-02-14
HUT71873A (en) 1996-02-28
FI950194A0 (fi) 1995-01-17
DE69309685T2 (de) 1997-10-16

Similar Documents

Publication Publication Date Title
EP0155387B1 (en) Fibronolytically active hybrid protein, process for its preparation and pharmaceutical composition
US7419948B2 (en) Treatment of hemophilia with human Factor IX produced in mammary tissue of transgenic mammals
PL184114B1 (pl) Środek farmaceutyczny do inhibicji aktywności czynnika tkankowego
EP0856317A1 (en) A stabilized mixture comprising fibrinogen
Kornalik Toxins affecting blood coagulation and fibrinolysis
EP0196920A2 (en) Degraded species of tissue-type plasminogen activator, pharmaceutical composition and method of preparation
JPH04505326A (ja) プラスミノーゲン活性化剤とフィブリン断片との血栓ターゲットの錯体
WO1984001786A1 (en) Enzyme derivatives and their use in the treatment of thrombosis
US4190708A (en) Production of urokinase
JP2000508918A (ja) 精製されたマルチメラーゼ
CA2140427A1 (en) A two component fibrin-glue composition for improving in vitro fertilization
EP0151593A1 (en) ENZYMATIC DERIVATIVES.
EP0125269A1 (en) Pharmaceutically active compounds
Hatton et al. On the interaction of rabbit antithrombin III with the luminal surface of the normal and deendothelialized rabbit thoracic aorta in vitro
CA1283047C (en) Stabilized plasminogen activator precursor and method of producing the same
Bakos et al. Enzymatic and envelope-converting activities of pars recta oviductal fluid from Xenopus laevis
US5811279A (en) Method for activating prothrombin with polyethylene glycol
US4999194A (en) Two-chain urokinase plasminogen activators for treatment of thrombotic disease
EP0251806B1 (en) Plasminogen activator production
Ghorbanpur et al. Purification and partial characterization of a coagulant serine protease from the venom of the Iranian snake Agkistrodon halys
EP0651659B1 (en) A two component fibrin-glue composition for improving in vitro fertilization
KR20010005626A (ko) 혈관 질환의 치료 방법
Chatterjee et al. Purification of human seminal acrosin inhibitor and its kinetics
Endege et al. Purification and characterization of two fibrinolysins from the midgut of adult female Glossina morsitans centralis
Houck et al. Gollagenolytic Activity of Mammalian Pancreas.

Legal Events

Date Code Title Description
FZDE Discontinued